Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer

Published:2010-03-14 Issue:3 Volume:28 Page:391-398
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Reuter Christoph W. M.,Morgan Michael A.,Ivanyi Philipp,Fenner Martin,Ganser Arnold,Grünwald Viktor

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-010-0527-5.pdf

Reference30 articles.

1. Shelley M, Harrioson C, Coles B et al (2010) Chemotherapy for hormone-refractory prostate cancer (review). Cochrane Database of systematc reviews 2006. Issue 4. Art. No.: CD005247. doi: 10.1002/14651858.CD005247.pub2

2. Garmey EG, Sartor O, Halabi S, Vogelzang NJ (2008) Second-line chemotherapy for advanced hormone-refractory prostate cancer. Clin Adv Hematol Oncol. 6(118–22):127–132

3. Michels J, Montemurro T, Murray N, Kollmannsberger C, Nguyen Chi K (2006) First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer: does sequence matter? Cancer 106:1041–1046

4. Lainakis G, Nikos A, Gerassimos A et al (2008) Biweekly doxorubicin/ketoconazole as second-line treatment in docetaxel-resistant, hormone-refractory prostate cancer. Urology 71:1181–1185

5. Nelius T, Klatte T, de Riese W, Haynes A, Filleur S (2009) Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy. Med Oncol [Epub ahead of print]

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in platinum chemotherapy for metastatic castration-resistant prostate cancer: Insights and perspectives;Cancer Treatment Reviews;2024-11

2. Novel treatment strategies to overcome resistance in prostate cancer;Therapy Resistance in Prostate Cancer;2024

3. Docetaxel Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis in Prostate Cancer Cells via Epigenetic Gene Regulation by Enhancer of Zeste Homolog 2;The World Journal of Men's Health;2023

4. Chemotherapy in metastatic castration-resistant prostate cancer: Current scenario and future perspectives;Cancer Letters;2021-12

5. Efficacy of docetaxel combined carboplatin for the treatment of patients with castration-resistant prostate cancer;Medicine;2020-05-22